enGene Holdings Inc. Warrants
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGen… Read more
Market Cap & Net Worth: enGene Holdings Inc. Warrants (ENGNW)
enGene Holdings Inc. Warrants (NASDAQ:ENGNW) has a market capitalization of $20.21K ($20.21K) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #19538 globally and #7177 in its home market, demonstrating a -7.08% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying enGene Holdings Inc. Warrants's stock price $2.23 by its total outstanding shares 9063 (9.06K).
enGene Holdings Inc. Warrants Market Cap History: 2022 to 2026
enGene Holdings Inc. Warrants's market capitalization history from 2022 to 2026. Data shows growth from $1.36K to $20.21K (49.06% CAGR).
enGene Holdings Inc. Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how enGene Holdings Inc. Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of ENGNW by Market Capitalization
Companies near enGene Holdings Inc. Warrants in the global market cap rankings as of March 19, 2026.
Key companies related to enGene Holdings Inc. Warrants by market ranking:
- SWANDEF (NSE:SWANDEF): Ranked #19529 globally with a market cap of $73.39 Million USD ( ₹6.36 Billion INR).
- Renascor Resources Limited (PINK:RSNUF): Ranked #19530 globally with a market cap of $73.35 Million USD.
- Mogan Enerji Yatırım Holding As (IS:MOGAN): Ranked #19539 globally with a market cap of $73.20 Million USD ( TL2.60 Billion TRY).
- Hope Education Group Co. Ltd (F:HE1): Ranked #19540 globally with a market cap of $73.18 Million USD ( €71.29 Million EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #19529 | SWANDEF | NSE:SWANDEF | $73.39 Million | ₹2399.10 |
| #19530 | Renascor Resources Limited | PINK:RSNUF | $73.35 Million | $0.03 |
| #19539 | Mogan Enerji Yatırım Holding As | IS:MOGAN | $73.20 Million | TL9.94 |
| #19540 | Hope Education Group Co. Ltd | F:HE1 | $73.18 Million | €0.02 |
enGene Holdings Inc. Warrants Historical Marketcap From 2022 to 2026
Between 2022 and today, enGene Holdings Inc. Warrants's market cap moved from $1.36K to $ 20.21K, with a yearly change of 49.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $20.21K | -24.66% |
| 2025 | $26.83K | +251.00% |
| 2024 | $7.64K | -0.79% |
| 2023 | $7.70K | +466.67% |
| 2022 | $1.36K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of enGene Holdings Inc. Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.21K USD |
| MoneyControl | $20.21K USD |
| MarketWatch | $20.21K USD |
| marketcap.company | $20.21K USD |
| Reuters | $20.21K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.